Skip to main content

uniQure to Participate in Multiple Upcoming Industry Conferences in November

Written by Customer Service on . Posted in Public Companies.

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 04, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that members of uniQure’s management team including Matt Kapusta, chief executive officer, Ricardo Dolmetsch, Ph.D., president of research & development, and Maria Cantor, chief communications officer, with Chiara Russo, associate director of investor relations and communications, will participate in the following upcoming conferences in November:
Credit Suisse 29thAnnual Virtual Healthcare Conference, November 9 – 12, 2020— A fireside chat including Matt Kapusta and Dr. Dolmetsch with research analyst Martin Auster will take place on Monday, November 9, 2020 from 4:15 – 4:55 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investor section of the uniQure website. The webcast replay will be available for at least 72 hours following the live event.

— Members of uniQure’s management team also will participate in virtual one-on-one investor meetings throughout the day.

Barclay’s Gene Editing & Gene Therapy Summit, November 16, 2020— A fireside chat with Matt Kapusta and research analyst Gena Wang will take place on Monday, November 16, 2020 from 2:30 – 2:55 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investor section of the uniQure website. The webcast replay will be available for at least 72 hours following the live event.

— Members of uniQure’s management team also will participate in virtual one-on-one investor meetings throughout the day.

Stifel 2020 Virtual Healthcare Conference, November 16 – 18, 2020— A fireside chat with Dr. Dolmetsch and research analyst Paul Matteis will take place on Tuesday, November 17, 2020 from 8:00 – 8:30 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investor section of the uniQure website. The webcast replay will be available for at least 72 hours following the live event.

— Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day.

About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington’s disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases. www.uniQure.comuniQure Contacts:

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.